Insulin activates a rat liver peripheral plasma-membrane cyclic AMP phosphodiesterase by a phosphorylation mechanism

Phosphorylation of PDE4A5 by MAPKAPK2 attenuates fibrin degradation via p75 signalling.

Journal of biochemistry·2019

FBXW7 regulates DISC1 stability via the ubiquitin-proteosome system.

Molecular psychiatry·2017

Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progression.

British journal of cancer·2015

The cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma membrane of VCaP prostate cancer cells.

British journal of cancer·2014

Epac and the high affinity rolipram binding conformer of PDE4 modulate neurite outgrowth and myelination using an in vitro spinal cord injury model.

British journal of pharmacology·2014

Disruption of the cyclic AMP phosphodiesterase-4 (PDE4)-HSP20 complex attenuates the β-agonist induced hypertrophic response in cardiac myocytes.

Journal of molecular and cellular cardiology·2011

Overview of pathways and dynamic interactions of c-type cytochromes in Geobacter sulfurreducens.

Biochemical Society transactions·2026

Building peroxisomes: perspectives on plant peroxins.

Biochemical Society transactions·2026

The diverse gating mechanisms of bacterial MscS-like ion channels.

Biochemical Society transactions·2026

NINJ1: implications for plasma membrane rupture and disease.

Biochemical Society transactions·2026

Nitric oxide as a mechanistic link between metabolic dysfunction and cognitive decline in type 2 diabetes.

Biochemical Society transactions·2026

Ubiquitin E3 ligase activity in TRIpartite Motif (TRIM) family proteins.

Biochemical Society transactions·2026

Biochemical characteristics associated with spironolactone use in hospitalized patients with hypotonic hyponatraemia.

Annals of medicine·2026

The safety and efficacy of drug-coated balloon dilation system (Keeway) for benign prostate hyperplasia: a preclinical study.

World journal of urology·2026

Pharmacokinetics, mass balance, and metabolism of [14C]SPH3127 (sitokiren), a novel direct renin inhibitor in humans.

Frontiers in pharmacology·2026

Effect of Sodium C-Tetra(propyl)resorcin[4]tetrasulfonate (Na4PRA) on Antituberculosis Drugs as Seen by Diffusometry and NMR Spectroscopy.

International journal of molecular sciences·2026

Preclinical Pharmacokinetic and Pharmacological Profiling of B339, a Novel SARM1 Inhibitor for the Treatment of Vincristine-induced Peripheral Neuropathy.

Pharmaceutical research·2026

Pharmacodynamics of Boronic Acids and Boronates.

Handbook of experimental pharmacology·2026

Related Experiment Videos

Insulin activates a rat liver peripheral plasma-membrane cyclic AMP phosphodiesterase by a phosphorylation mechanism

Related Concept Videos

Phosphorylation of PDE4A5 by MAPKAPK2 attenuates fibrin degradation via p75 signalling.

FBXW7 regulates DISC1 stability via the ubiquitin-proteosome system.

Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progression.

The cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma membrane of VCaP prostate cancer cells.

Epac and the high affinity rolipram binding conformer of PDE4 modulate neurite outgrowth and myelination using an in vitro spinal cord injury model.

Disruption of the cyclic AMP phosphodiesterase-4 (PDE4)-HSP20 complex attenuates the β-agonist induced hypertrophic response in cardiac myocytes.

Overview of pathways and dynamic interactions of c-type cytochromes in Geobacter sulfurreducens.

Building peroxisomes: perspectives on plant peroxins.

The diverse gating mechanisms of bacterial MscS-like ion channels.

NINJ1: implications for plasma membrane rupture and disease.

Nitric oxide as a mechanistic link between metabolic dysfunction and cognitive decline in type 2 diabetes.

Ubiquitin E3 ligase activity in TRIpartite Motif (TRIM) family proteins.

Biochemical characteristics associated with spironolactone use in hospitalized patients with hypotonic hyponatraemia.

The safety and efficacy of drug-coated balloon dilation system (Keeway) for benign prostate hyperplasia: a preclinical study.

Pharmacokinetics, mass balance, and metabolism of [14C]SPH3127 (sitokiren), a novel direct renin inhibitor in humans.

Effect of Sodium C-Tetra(propyl)resorcin[4]tetrasulfonate (Na4PRA) on Antituberculosis Drugs as Seen by Diffusometry and NMR Spectroscopy.

Preclinical Pharmacokinetic and Pharmacological Profiling of B339, a Novel SARM1 Inhibitor for the Treatment of Vincristine-induced Peripheral Neuropathy.

Pharmacodynamics of Boronic Acids and Boronates.

Related Experiment Videos

Insulin activates a rat liver peripheral plasma-membrane cyclic AMP phosphodiesterase by a phosphorylation mechanism

Related Concept Videos

Related Articles